Coherent Collection of Uniformly Organized Short Reviews in the Field of Therapeutic...
Coherent Collection of Uniformly Organized Short Reviews in the Field of Therapeutic Genetic Medicine
DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c91850) has announced the
addition of "Concepts in Genetic Medicine" to their offering.
Concepts in Genetic Medicine offer a coherent collection of
uniformly organized short reviews in the field of therapeutic genetic
medicine. Each chapter focuses on a current topic ("concept") to
elucidate issues in development of genetic treatments for discuses,
presenting critical challenges, strategies for addressing them, and
future directions.
-0-
*T
Key Topics:
- The Evolution of Human Gene Therapy. A Journey from Excessive Hype
to Excessive Diffidence to Realty
- Murine Leukemia Virus Based Vectors
- Lentivirus Vectors
- Adenoviral Vectors: History and Perspective
- Adeno-associated Virus Vectors
- The Glass is Half Full: the Goal of Long-term delivery may be
Approachable Using SV40-derived Vectors
- Herpes Simplex Virus Vectors
- Nonviral Gene Delivery Systems
- Therapeutic Gene Transfer to Skeletal Muscle
- Gene Therapy for Cardiovascular Disease
- Intra-articular Vector Delivery for Inflammatory Disease
- The Respiratory System as a Platform for Gene Delivery
- The Brain as a Target for Gene Therapy
- Immune Responses to Viral vectors Injected Systemically or into the
CNS
- Cancer vaccines
- Genetically Modified T cells for Human Gene Therapy
- Lentiviral Vector Delivery of RNAi Triggers for the Treatment of
HIV-1 Infection
- The Manufacture of Genetic Viral Vector Products
- The Manufacture of Adeno-associated Viral Vectors
- Lentivirus Vector Manufacturing
- Safety and Regulatory.
- Assays for the Release of Viral Vector Gene Therapy Products for
Clinical Trials
- Safety of Retroviral Vectors: Regulatory and Technical
Considerations
- Assays for the Quality Control of Lentiviral Vectors
- Assays for Non-viral vectors
- Assays for the Release of Cellular Gene Therapy Products
- Toxicology for Gene Therapy Products: Concepts and Challenges
- Regulatory Aspects of Gene Therapy Medicinal Products in the
European Union
- Venture Capital and Biotechnology Startups
- The role of Investment Banking in the Growth of Biotechnology
Companies
- Managing Reimbursment for Gene Therapy Products
*T
For more information visit
http://www.researchandmarkets.com/reports/c91850.
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980
Copyright Business Wire 2008
